Identification and Validation of a Gene Signature for Lower-Grade Gliomas Based on Pyroptosis-Related Genes to Predict Survival and Response to Immune Checkpoint Inhibitors

Figure 7

The relationship between TME and OS, and PRS gene signature. (a-b) Kaplan-Meier survival analysis of immune score and stromal score in TCGA. (c-d) Kaplan-Meier survival analysis of immune score and stromal score in CGGA. (e-f) The immune score and stromal score between the high-risk group and low-risk group in TCGA. (g-h) The immune score and stromal score between the high-risk group and low-risk group in CGGA. Data in (e-h) were analyzed by Wilcoxon test; ^∗p < 0.05, ^∗∗p < 0.01, ^∗∗∗p < 0.001, and ^∗∗∗∗p < 0.0001.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)